TC
TCG Crossover GP I, LLC cut its SLN stake below 5%
TCG Crossover GP I, LLC reported owning 3.9% of Silence Therapeutics plc (SLN) (5,457,105 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G